ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.042,36
-0,06%
Brent Oil
83,76
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Generex Biotechnology Corporation (CE) (GNBT)

  7. Generex Biotechnology Corporation (CE) (GNBT) Notícias

GNBT

Generex Biotechnology (CE) (GNBT)

Generex Biotechnology Corporation (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:GNBT
DataHoraFonteTítuloCódigoCompanhia
23/07/202108:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GNBTGenerex Biotechnology Corporation (CE)
21/06/202116:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GNBTGenerex Biotechnology Corporation (CE)
14/06/202118:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GNBTGenerex Biotechnology Corporation (CE)
29/10/202018:01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:GNBTGenerex Biotechnology Corporation (CE)
06/10/202014:29InvestorsHub NewsWire(GNBT,PAOG) SPAC Trend Comes To Biotech MarketUSOTC:GNBTGenerex Biotechnology Corporation (CE)
21/09/202010:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GNBTGenerex Biotechnology Corporation (CE)
11/09/202017:00Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:GNBTGenerex Biotechnology Corporation (CE)
09/09/202013:54Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:GNBTGenerex Biotechnology Corporation (CE)
31/08/202011:03InvestorsHub NewsWireGNBT - Vying for vaccinesUSOTC:GNBTGenerex Biotechnology Corporation (CE)
20/08/202018:17Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:GNBTGenerex Biotechnology Corporation (CE)
29/06/202015:29Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:GNBTGenerex Biotechnology Corporation (CE)
19/06/202014:10Edgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)USOTC:GNBTGenerex Biotechnology Corporation (CE)
04/05/202011:02InvestorsHub NewsWireGenerex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 PandemicUSOTC:GNBTGenerex Biotechnology Corporation (CE)
28/04/202015:05InvestorsHub NewsWireGenerex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Tr...USOTC:GNBTGenerex Biotechnology Corporation (CE)
27/04/202013:07InvestorsHub NewsWireGNBT Publishes Response to Congressional Letter Calling for COVID-19 Challenge Studies and Alternative SolutionsUSOTC:GNBTGenerex Biotechnology Corporation (CE)
13/02/202016:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:GNBTGenerex Biotechnology Corporation (CE)
29/11/201915:34Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:GNBTGenerex Biotechnology Corporation (CE)
25/11/201913:45InvestorsHub NewsWireGNBT - Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc.USOTC:GNBTGenerex Biotechnology Corporation (CE)
12/11/201911:31Edgar (US Regulatory)Annual Report (10-k)USOTC:GNBTGenerex Biotechnology Corporation (CE)
05/11/201912:38InvestorsHub NewsWireGNBT Announces First-in-Human Clinical Trial of ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli C...USOTC:GNBTGenerex Biotechnology Corporation (CE)
31/10/201911:51InvestorsHub NewsWireGNBT - BioPharma w/10x Potential - Cancer and Diabetes Treatments - Nasdaq Up ListUSOTC:GNBTGenerex Biotechnology Corporation (CE)
29/10/201916:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:GNBTGenerex Biotechnology Corporation (CE)
23/10/201915:32InvestorsHub NewsWireWHY GNBT COULD MOVE BIG SOONUSOTC:GNBTGenerex Biotechnology Corporation (CE)
01/10/201913:37InvestorsHub NewsWireGenerex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled SyringeUSOTC:GNBTGenerex Biotechnology Corporation (CE)
24/09/201917:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:GNBTGenerex Biotechnology Corporation (CE)
18/09/201910:26InvestorsHub NewsWireGNBT - GENEREX BIOTECHNOLOGY ASSEMBLING MASSIVE GROWTH MACHINEUSOTC:GNBTGenerex Biotechnology Corporation (CE)
17/09/201910:29InvestorsHub NewsWireGNBT Announces 1st Phase II Clinical Trial Patient for Treatment of Triple Negative Breast CancerUSOTC:GNBTGenerex Biotechnology Corporation (CE)
12/09/201914:29InvestorsHub NewsWireGNBT Announces On-Demand Corprate Webcast From 21st Annual H.C. Wainwright Global Healthcare Investment ConferenceUSOTC:GNBTGenerex Biotechnology Corporation (CE)
11/09/201916:46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GNBTGenerex Biotechnology Corporation (CE)
10/09/201912:34InvestorsHub NewsWireGNBT - Generex Signs LOI to Establish NuGenerex Health MSO with Arizona Endocrinology Center & Paradise Valley Family MedicineUSOTC:GNBTGenerex Biotechnology Corporation (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:GNBT

Seu Histórico Recente

BITMOT
889989
Btp Tf 0,5% Lg28 Eur
COIN
ADASTUSD
ASX
WABRA
LSE
0F2N
Groupe Ldlc
NASDAQ
AAWYWXX
Morgan Stanley Finance L...
LATK
WSIENNAUSDT
Sienna
COIN
EOSDACUSD
eosDAC
BIT
UB5UK3
Unicredit Bank
ASX
FWLR
GDAX
REQUSD
Request
COIN
AUDUST
Aussie Digital
COIN
IOEEUR
TIDE
AGIBTC
AMEX
DHC.X
EU
E277S
E277S
LSE
ZO43
Cred Ag Co 30
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados